The tariff classification of Omeprazole (CAS No. 73590-58-6) in bulk powder form, from Croatia
Issued December 27, 2024 by U.S. Customs and Border Protection.
Tariff classification
HTS codes: 2933.39.4100
Headings: 2933
Product description
damage and ulcers caused by gastric acid and H. pylori infection. The applicable subheading for the Omeprazole in bulk powder form will be 2933.39.4100, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Heterocyclic compounds with nitrogen hetero-atom(s) only: Compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure: Other: Other: Drugs: Other.” Pursuant to General Note 13, HTSUS, the rate of duty will be free. This merchandise may be subject to the Federal Food, Drug, and Cosmetic Act and/or The Public Health Security and Bioterrorism Preparedness and Response Act of 2002 (The Bioterrorism Act), which are administered by the U.S. Food and Drug Administration (FDA). Information on the Federal Food, Drug, and Cosmetic Act, as well as The Bioterrorism Act, can be obtained by calling the FDA at 1-888-463-6332, or by visiting their website at www.fda.gov. Duty rates are provided for your convenience and are subject to change. The text of the most recent HTSUS and the accompanying duty rates are provided at https://hts.usitc.gov/. The
CBP rationale
The applicable subheading for the Omeprazole in bulk powder form will be 2933.39.4100, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Heterocyclic compounds with nitrogen hetero-atom(s) only: Compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure: Other: Other: Drugs: Other.
Full text
N344795 December 27, 2024 CLA-2-29:OT:RR:NC:N3:138 CATEGORY: Classification TARIFF NO.: 2933.39.4100 Karen Stutman Ren Pharm International Ltd. 350 Jericho Turnpike, Suite 204Jericho, NY 11753 RE: The tariff classification of Omeprazole (CAS No. 73590-58-6) in bulk powder form, from Croatia Dear Ms. Stutman: In your letter dated December 20, 2024, you requested a tariff classification ruling. Omeprazole is in a class of medications called proton-pump inhibitors and works by decreasing the amount of acid made in the stomach. It is used to treat GERD associated conditions such as heartburn and gastric acid hypersecretion, and to promote healing of tissue damage and ulcers caused by gastric acid and H. pylori infection. The applicable subheading for the Omeprazole in bulk powder form will be 2933.39.4100, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Heterocyclic compounds with nitrogen hetero-atom(s) only: Compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure: Other: Other: Drugs: Other.” Pursuant to General Note 13, HTSUS, the rate of duty will be free. This merchandise may be subject to the Federal Food, Drug, and Cosmetic Act and/or The Public Health Security and Bioterrorism Preparedness and Response Act of 2002 (The Bioterrorism Act), which are administered by the U.S. Food and Drug Administration (FDA). Information on the Federal Food, Drug, and Cosmetic Act, as well as The Bioterrorism Act, can be obtained by calling the FDA at 1-888-463-6332, or by visiting their website at www.fda.gov. Duty rates are provided for your convenience and are subject to change. The text of the most recent HTSUS and the accompanying duty rates are provided at https://hts.usitc.gov/. The holding set forth above applies only to the specific factual situation and merchandise description as identified in the ruling request. This position is clearly set forth in Title 19, Code of Federal Regulations (CFR), Section 177.9(b)(1). This section states that a ruling letter is issued on the assumption that all of the information furnished in the ruling letter, whether directly, by reference, or by implication, is accurate and complete in every material respect. In the event that the facts are modified in any way, or if the goods do not conform to these facts at time of importation, you should bring this to the attention of U.S. Customs and Border Protection (CBP) and submit a request for a new ruling in accordance with 19 CFR 177.2. Additionally, we note that the material facts described in the foregoing ruling may be subject to periodic verification by CBP. This ruling is being issued under the provisions of Part 177 of the Customs and Border Protection Regulations (19 C.F.R. 177). A copy of the ruling or the control number indicated above should be provided with the entry documents filed at the time this merchandise is imported. If you have any questions regarding the ruling, please contact National Import Specialist Judy Lee at [email protected]. Sincerely, Steven A. Mack Director National Commodity Specialist Division
More rulings on the same tariff codes
The tariff classification of Roflumilast (CAS No. 162401-32-3), imported in bulk form, from Mexico
The tariff classification of Vilanterol Trifenatate (CAS No. 503070-58-4) in bulk powder form and Umeclidinium Bromide (CAS No. 869113-09-7) in bulk powder form, from India
The tariff classification of Revefenacin (CAS No. 864750-70-9) in bulk form, from France
The tariff classification of Maropitant Citrate Monohydrate (CAS No. 359875-09-5) in bulk power form, from Italy
The tariff classification of Maropitant (CAS No. 147116-67-4) in bulk powder form, from Italy
The tariff classification of Difelikefalin Acetate (CAS No. 1024829-44-4) in bulk form, from Taiwan
The tariff classification of Tolperisone Hydrochloride (CAS No. 3644-61-9) in bulk form, from Mexico and Austria
The tariff classification of Brompheniramine Maleate (CAS No. 980-71-2) in bulk form, from India
The tariff classification of Pyrilamine Maleate (CAS No. 59-33-6) in bulk form, from India
The tariff classification of Ropivacaine Hydrochloride Monohydrate (CAS No. 132112-35-7) in bulk powder form, from Belgium
Searching CBP rulings the smart way
TariffLens semantically searches all 200,000+ CBP rulings, surfaces the ones that actually match your product, and builds defensible classifications backed by ruling citations.
Book a demo →